Open Access. Powered by Scholars. Published by Universities.®

Bacterial Infections and Mycoses Commons™

Open Access. Powered by Scholars. Published by Universities.®

1,111 Full-Text Articles 3,801 Authors 672,984 Downloads 146 Institutions

All Articles in Bacterial Infections and Mycoses

Faceted Search

1,111 full-text articles. Page 53 of 53.

Interactions Of Francisella Tularensis With Components Of The Host Fibrinolytic System, Shawn Russell Clinton 2010 University of Tennessee Health Science Center

Interactions Of Francisella Tularensis With Components Of The Host Fibrinolytic System, Shawn Russell Clinton

Theses and Dissertations (ETD)

Francisella tularensis (FT) is a Gram-negative coccobacillus and causative agent of a life-threatening disease commonly referred to as tularemia. Due to the highly infectious nature of the organism, its previous development as a biowarfare agent and its potential use in acts of bioterrorism, this bacterium is listed as a Category A select agent by the Centers for Disease Control and Prevention (CDC). Efforts to understand the pathogenic mechanisms of FT within the host environment are vital for the development of safe and effective vaccines, as well as treatments, against tularemia. Though considered an intracellular pathogen, FT research of late has …


Is There An Association Of Giardiasis With Beta-Thalassemia Minor?, Javed Yakoob, Wasim Jafri, Hizbullah Shaikh 2010 Aga Khan University

Is There An Association Of Giardiasis With Beta-Thalassemia Minor?, Javed Yakoob, Wasim Jafri, Hizbullah Shaikh

Section of Gastroenterology

Beta–thalassemia minor is a symptomless carrier state of a hemoglobinopathy which predisposes to bacterial infections. We report three cases presenting with giardiasis, a parasitic infection of gastrointestinal tract caused by Giardia lamblia. Patients presented with recurrent diarrhea and abdominal pain for over a year. An esophagogastroduodenoscopy finding varied from normal to acute duodenitis. Duodenal biopsy demonstrated changes consistent with mild chronic non-specific inflammation with G. lamblia trophozoites. All three patients were diagnosed as β -thalassemia minor hemoglobin electrophoresis. They were treated with Diloxanide furoate 500 mg and Metronidazole 400mg three times daily for five days. Their symptoms resolved and a …


Transcriptional Regulation Of Azole Antifungal Resistance And Tolerance In Candida Glabrata, Kelly E. Caudle 2010 University of Tennessee Health Science Center

Transcriptional Regulation Of Azole Antifungal Resistance And Tolerance In Candida Glabrata, Kelly E. Caudle

Theses and Dissertations (ETD)

Azole antifungal resistance has emerged as a significant problem in the management of infections caused by fungi including Candida species. In recent years, Candida glabrata has become the second most common cause of mucosal and invasive fungal infections in humans second to Candida albicans. Not only are systemic C. glabrata infections characterized by high mortality rates, treatment failures to the azole class of antifungals, the most widely used antifungal for treatment of Candida infections, have been reported. Contributing to this problem, C. glabrata exhibits intrinsic reduced susceptibility to the azole antifungals, and the development of high-level azole resistance …


Cholera: An Overview Of A Disease, Ezriel Leifer 2010 Touro College

Cholera: An Overview Of A Disease, Ezriel Leifer

The Science Journal of the Lander College of Arts and Sciences

Although the disease, cholera, has been recognized since antiquity, the bacteria responsible for causing it was only discovered in the mid-19th century. Since 1817, cholera has spread on a global basis to cause seven pandemics. According to information reported to the World Health Organization in 1999, almost 8,500 people died and another 223,000 became sick with cholera worldwide. During the period between full outbreaks, the cholera organism, Vibrio cholerae, thrives in brackish waters, in harmless as well as disease-causing forms. Vibrio cholerae is just one of a variety of ocean-borne microbes that can sicken humans via seafood, drinking water, and …


Clostridium Difficile Associated Disease (Cdad), Rivka H. Borger 2010 Touro College

Clostridium Difficile Associated Disease (Cdad), Rivka H. Borger

The Science Journal of the Lander College of Arts and Sciences

Clostridium difficile bacteria (C. difficile) are a spore-forming species of bacteria that lies dormant in the colon, in the presence of normal intestinal flora. Due to overuse of certain antibiotics, normal intestinal bacteria may be depleted, and combined with other possible risk factors, allow C. difficile bacterial spores to develop into active, infectious, and extremely resistant toxin-producing bacteria. The toxins cause severe damage and inflammation to the intestinal wall that can result in gastrointestinal discomfort and severe pseudomembranous enterocolitis that must be treated with a low-risk C. difficile targeting defense.


Rapid Emergence Of Co-Colonization With Community-Acquired And Hospital-Acquired Methicillin-Resistant Staphylococcus Aureus Strains In The Hospital Setting, Joanna R. Wares, Erika M.C. D'Agata, Glenn F. Webb 2010 University of Richmond

Rapid Emergence Of Co-Colonization With Community-Acquired And Hospital-Acquired Methicillin-Resistant Staphylococcus Aureus Strains In The Hospital Setting, Joanna R. Wares, Erika M.C. D'Agata, Glenn F. Webb

Department of Math & Statistics Faculty Publications

Background: Community-acquired methicillin-resistant Staphylococcus aureus (CAMRSA), a novel strain of MRSA, has recently emerged and rapidly spread in the community. Invasion into the hospital setting with replacement of the hospital-acquired MRSA (HA-MRSA) has also been documented. Co-colonization with both CA-MRSA and HA-MRSA would have important clinical implications given differences in antimicrobial susceptibility profiles and the potential for exchange of genetic information.

Methods: A deterministic mathematical model was developed to characterize the transmission dynamics of HA-MRSA and CA-MRSA in the hospital setting and to quantify the emergence of co-colonization with both strains Results: The model analysis shows that the …


The Rapid Identification Of Novel Anti-Mycobacterial Drugs And The Transporters Involved In Their Resistance, James Carroll 2010 Department of Biological Sciences, Cork Institute of Technology, Cork, Ireland.

The Rapid Identification Of Novel Anti-Mycobacterial Drugs And The Transporters Involved In Their Resistance, James Carroll

Theses

Despite the success of anti-mycobacterial drugs over the past 70 years, mycobacterial disease, particularly tuberculosis is still responsible for millions of deaths worldwide. Additionally, the emergence of Multidrug Resistant (MDR-TB) and Extensively Drug Resistant (XDR-TB) Tuberculosis throughout the world has motivated calls by the World Health Organization for novel mycobacterial drugs, vaccines and diagnostic tests. Consequently, this study sought to identify and evaluate the efficacy of a range of anti-mycobacterial compounds against a representative cohort of pathogenic mycobacterial species. The development and employment of the rapid, robust and inexpensive microtitre alamarBlue assay (MABA) facilitated the assessment of a vast array …


Evaluating Children With Otitis Media For Bacteremia Or Urinary Tract Infection., Daniel Yawman, Patrick Mahar, Aaron Blumkin, Gregory P. Conners 2010 Children's Mercy Hospital

Evaluating Children With Otitis Media For Bacteremia Or Urinary Tract Infection., Daniel Yawman, Patrick Mahar, Aaron Blumkin, Gregory P. Conners

Manuscripts, Articles, Book Chapters and Other Papers

Background. It is unclear if clinicians evaluate for concurrent bacteremia or UTI in young patients diagnosed with acute otitis media (AOM). Objectives. To describe how often, and under which circumstances, emergency providers investigate for bacteremia or UTI in 2-36 month olds with AOM. Methods. Cases of AOM were analyzed from the 2001-2004 National Hospital Ambulatory Medical Care Survey (NHAMCS)-Emergency Department dataset. Results. AOM was diagnosed in 17% of the 10,847 recorded visits of 2-36 month olds. Of these visits, laboratory testing included: CBC: 7%, Blood culture: 4%, urinalysis or urine culture: 5%, and any of these tests: 9%. Rates of …


Digital Commons powered by bepress